United Services Automobile Association lowered its position in shares of Masimo Corporation (NASDAQ:MASI) by 47.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,820 shares of the medical equipment provider’s stock after selling 7,850 shares during the period. United Services Automobile Association’s holdings in Masimo Corporation were worth $823,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the stock. Neuburgh Advisers LLC increased its position in shares of Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 80 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 434 shares during the period. Dubuque Bank & Trust Co. bought a new position in shares of Masimo Corporation during the first quarter worth $169,000. Glen Harbor Capital Management LLC increased its position in shares of Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock worth $170,000 after buying an additional 110 shares during the period. Finally, Bancorpsouth Inc. bought a new position in shares of Masimo Corporation during the first quarter worth $203,000. Hedge funds and other institutional investors own 83.56% of the company’s stock.
Shares of Masimo Corporation (MASI) traded up 2.02% during mid-day trading on Monday, hitting $98.13. 285,523 shares of the stock were exchanged. The stock’s 50-day moving average price is $92.09 and its 200-day moving average price is $87.67. The company has a market cap of $5.02 billion, a P/E ratio of 16.66 and a beta of 0.80. Masimo Corporation has a 52-week low of $51.10 and a 52-week high of $104.71.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, May 3rd. The medical equipment provider reported $0.82 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.22. The company had revenue of $186.30 million for the quarter, compared to analyst estimates of $184.14 million. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.53 earnings per share. Equities research analysts anticipate that Masimo Corporation will post $2.66 earnings per share for the current fiscal year.
WARNING: This piece was reported by BNB Daily and is the sole property of of BNB Daily. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.baseball-news-blog.com/2017/07/24/united-services-automobile-association-lowers-position-in-masimo-corporation-masi-updated.html.
MASI has been the topic of a number of research analyst reports. Wedbush restated an “outperform” rating and set a $100.00 price objective on shares of Masimo Corporation in a research report on Tuesday, April 4th. Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 11th. BidaskClub downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, July 5th. Stifel Nicolaus initiated coverage on shares of Masimo Corporation in a research report on Monday, July 10th. They issued a “buy” rating and a $105.00 price target on the stock. Finally, Roth Capital increased their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Masimo Corporation presently has a consensus rating of “Hold” and an average target price of $87.00.
In related news, Director Sanford Fitch sold 6,000 shares of Masimo Corporation stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the transaction, the director now directly owns 89,249 shares in the company, valued at approximately $8,201,090.61. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Yongsam Lee sold 10,000 shares of Masimo Corporation stock in a transaction on Tuesday, April 25th. The shares were sold at an average price of $100.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the executive vice president now owns 79,000 shares in the company, valued at $7,900,000. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 471,201 shares of company stock worth $46,790,376. Insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Masimo Corporation and related companies with MarketBeat.com’s FREE daily email newsletter.